Modeling All age groups Tuberculosis
Efficacy/effectiveness Safety Newborn (0-1 years) Adolescents (10-18 years) Adults (18+) Tuberculosis
meeting agenda Agenda & Minutes United Kingdom Ebola Yellow fever Influenza Tuberculosis Human papillomavirus (HPV)
Download:
NITAG recommendation Recommendation United States of America Diphtheria Tetanus Pertussis
Download:
Efficacy/effectiveness Safety Coverage All age groups Canada Tuberculosis
Coverage Newborn (0-1 years) Children (2-9 years) Mumps Diphtheria Tetanus Pertussis Measles Rubella Poliomyelitis
Economic aspects All age groups Healthcare workers Tuberculosis
Efficacy/effectiveness Safety Newborn (0-1 years) Adolescents (10-18 years) Adults (18+) Tuberculosis
Administration Efficacy/effectiveness Safety Newborn (0-1 years) Hepatitis B Diphtheria Pertussis Tetanus Haemophilus influenzae type B Poliomyelitis
Efficacy/effectiveness Safety Administration All age groups Tuberculosis